AXSM ALERT: Klein Law Firm

NEW YORK, May 31, 2022 /PRNewswire/ — Klein Law Firm Announces Class Action Lawsuit Has Been Filed on Behalf of Axsome Therapeutics, Inc. (NASDAQ: AXSM) Shareholders Alleging the Company Violated Federal Securities Laws movables.

Class period: December 30, 2019 at April 22, 2022
Lead Applicant Deadline: July 12, 2022
No obligation or cost to you.

Learn more about your recoverable losses in AXSM:
https://www.kleinstocklaw.com/pslra-1/axsome-therapeutics-inc-loss-submission-form?id=27818&from=4

Axsome Therapeutics, Inc. NEWS – AXSM NEWS

CLASS ACTION CASE DETAILS: The filed complaint alleges that Axsome Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Axsome’s Chemistry, Manufacturing and Control Practices (“CMC” ) were deficient in AXS-07, the Company’s drug for the acute treatment of migraine, and its manufacturing process; (ii) as a result, it was unlikely that Axsome would submit the AXS-07 New Drug Application (“NDA”) within the timeframe originally anticipated; (iii) the above CMC issues remained unresolved at the time the United States Food and Drug Administration (“FDA”) reviewed the AXS-07 NDA; (iv) as a result, the FDA was unlikely to approve NDA AXS-07; (v) as a result of all of the foregoing, Axsome had overestimated the regulatory and commercial prospects of AXS-07; and (vi) as a result, the Company’s public statements were materially false and misleading at all material times.

WHAT THIS MEANS FOR YOU AS A SHAREHOLDER: If you have suffered a loss in Axsome, you have until July 12, 2022 ask the court to obtain the status of principal plaintiff. Your ability to participate in any collection does not require you to serve as the lead plaintiff.

AT NO CHARGE TO YOU: If you purchased Axsome securities during the relevant period, you may be entitled to compensation without payment of disbursements.

HOW TO PROTECT YOUR FINANCIAL INTERESTS: For more information on the AXSM trial, please contact J. Klein, Esq. by phone at 212-616-4899 or click on this link: https://www.kleinstocklaw.com/pslra-1/axsome-therapeutics-inc-loss-submission-form?id=27818&from=4.

ABOUT KLEIN LAW FIRM
J. Klein, Esq. represents investors and participates in securities litigation involving financial fraud across the country. Klein Law Firm is a litigation firm with experience in a wide range of areas, including securities law, corporate finance and commercial litigation. Since 2011, our experienced lawyers have achieved superior results for our clients with a personalized approach. Lawyer advertisement. Prior results do not guarantee similar results.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th floor
New York, NY 10118
[email protected]
Telephone: (212) 616-4899
www.kleinstocklaw.com

View original content: https://www.prnewswire.com/news-releases/axsm-alert-the-klein-law-firm-announces-a-lead-plaintiff-deadline-of-july-12-2022-in – the-class-action-filed-on-behalf-of-axsome-therapeutics-inc-shareholders-301557982.html

SOURCE Klein Law Firm